MDA-9/syntenin is a key regulator of glioma pathogenesis
Open Access
- 4 December 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 16 (1), 50-61
- https://doi.org/10.1093/neuonc/not157
Abstract
The extraordinary invasiveness of human glioblastoma multiforme (GBM) contributes to treatment failure and the grim prognosis of patients diagnosed with this tumor. Consequently, it is imperative to define further the cellular mechanisms that control GBM invasion and identify promising novel therapeutic targets. Melanoma differentiation associated gene–9 (MDA-9/syntenin) is a highly conserved PDZ domain–containing scaffolding protein that promotes invasion and metastasis in vitro and in vivo in human melanoma models. To determine whether MDA-9/syntenin is a relevant target in GBM, we investigated its expression in tumor samples and involvement in GBM invasion and angiogenesis. We assessed MDA-9/syntenin levels in available databases, patient tumor samples, and human-derived cell lines. Through gain-of-function and loss-of-function studies, we analyzed changes in invasion, angiogenesis, and signaling in vitro. We used orthotopic xenografts with GBM6 cells to demonstrate the role of MDA-9/syntenin in GBM pathogenesis in vivo. MDA-9/syntenin expression in high-grade astrocytomas is significantly higher than normal tissue counterparts. Forced overexpression of MDA-9/syntenin enhanced Matrigel invasion, while knockdown inhibited invasion, migration, and anchorage-independent growth in soft agar. Moreover, overexpression of MDA-9/syntenin increased activation of c-Src, p38 mitogen-activated protein kinase, and nuclear factor kappa-B, leading to elevated expression of matrix metalloproteinase 2 and secretion of interleukin-8 with corresponding changes observed upon knockdown. GBM6 cells that stably express small hairpin RNA for MDA-9/syntenin formed smaller tumors and had a less invasive phenotype in vivo. Our findings indicate that MDA-9/syntenin is a novel and important mediator of invasion in GBM and a key regulator of pathogenesis, and we identify it as a potential target for anti-invasive treatment in human astrocytoma.Keywords
This publication has 46 references indexed in Scilit:
- The UCSC Cancer Genomics Browser: update 2013Nucleic Acids Research, 2012
- Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2012
- L1 stimulation of human glioma cell motility correlates with FAK activationJournal of Neuro-Oncology, 2011
- Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-κBOncogene, 2010
- Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Cell migration in the normal and pathological postnatal mammalian brainProgress in Neurobiology, 2009
- mda -9/Syntenin promotes metastasis in human melanoma cells by activating c-SrcProceedings of the National Academy of Sciences of the United States of America, 2008
- The Role of Myosin II in Glioma Invasion of the BrainMolecular Biology of the Cell, 2008
- EGF regulates plasminogen activator inhibitor‐1 (PAI‐1) by a pathway involving c‐Src, PKCδ, and sphingosine kinase 1 in glioblastoma cellsThe FASEB Journal, 2007
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006